Summary
We report nine new patients with malonic aciduria associated with enzyme-confirmed malonyl-CoA decarboxylase (MCD) deficiency in eight. Clinical details were available on eight, and molecular genetic characterization was obtained for nine. As for 15 previously described patients, cardinal clinical manifestations included developmental delay and cardiomyopathy; metabolic perturbations (e.g. acidosis) and seizures, however, were infrequent or not observed in our patients. For all, detection of elevated malonic acid in urine (± increased C3DC acylcarnitine by analysis employing tandem mass spectrometry) led to pursuit of enzyme studies. MCD activities (nmol/h PER mg protein) revealed: control (n = 22), 16.2 ± 1.8 (SEM; range 5.7–46.2); patients (n = 8, assayed in duplicate), 1.7 ± 0.3 (10% of parallel control; range 0.6–2.8). Molecular characterization by DNA sequence analysis and multiplex ligation-dependent probe amplification revealed nine novel mutations (c.796C>T; p.Gln266X, c.481delC; p.Leu161CysfsX18, c.1367A>C; p.Tyr456Ser, c.1319G>T; p.Ser440Ile, c.1430C>T; p.Ser477Phe, c.899G>T; p.Gly300Val, c.799–1683_949–1293del3128, and two other large genomic deletions comprising exons 1 or the complete gene) and two known mutations in the MLYCD gene. Our findings increase the number of enzyme-confirmed MCD-deficient patients by >50%, and expand our understanding of the phenotypic and molecular heterogeneity of this rare disorder.
Similar content being viewed by others
Abbreviations
- C3DC:
-
malonylcarnitine
- CHF:
-
congestive heart failure
- MCD:
-
malonyl-CoA decarboxylase
- MCT:
-
medium-chain triglycerides
- MLPA:
-
multiplex ligation-dependent probe amplification
- NBS:
-
newborn screening
References
Bennett MJ, Harthcock PA, Boriack RL, Cohen JC (2001) Impaired mitochondrial fatty acid oxidative flux in fibroblasts from a patient with malonyl-CoA decarboxylase deficiency. Mol Genet Metab 73: 276–279.
Cuthbert KD, Dyck JRB (2005) Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation. Curr Hypertens Rep 7: 407–411.
de Wit MC, de Coo IF, Verbeek E, et al (2006) Brain abnormalities in a case of malonyl-CoA decarboxylase deficiency. Mol Genet Metab 87: 102–106.
Dyck JRB, Hopkins TA, Bonnet S, et al (2006) Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 114: 1721–1728.
Ficicioglu C, Chrisant MR, Payan I, Chace DH (2005) Cardiomyopathy and hypotonia in a 5-month-old infant with malonyl-CoA decarboxylase deficiency: potential for preclinical diagnosis with expanded newborn screening. Pediatr Cardiol 26: 881–883.
FitzPatrick DR, Hill A, Tolmie JL, Thorburn DR, Christodoulou J (1999) The molecular basis of malonyl-CoA decarboxylase deficiency. Am J Hum Genet 65: 318–326.
Gao J, Waber L, Bennett MJ, Gibson KM, Cohen JC (1999) Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase. J Lipid Res 40: 178–182.
Gibson KM, Potter M, Nowaczyk M, et al (2005) Six new patients with malonyl-CoA decarboxylase (MCD) deficiency: expanding the phenotypic heterogeneity. Mol Genet Metab 84: 219–220 (abstract).
Gregg AR, Warman AW, Thorburn DR, O'Brien WE (1998) Combined malonic and methylmalonic aciduria with normal malonyl-coenzyme A decarboxylase activity: a case supporting multiple aetiologies. J Inherit Metab Dis 21: 382–390.
Joly E, Bendayan M, Roduit R, Saha AK, Ruderman NB, Prentki M (2005) Malonyl-CoA decarboxylase is present in the cytosolic, mitochondrial and peroxisomal compartments of rat hepatocytes. FEBS Lett 570: 6581–6586.
Krishnamoorthy KS, Vianey-Sabin C, Shih VE (1999) Malonic aciduria due to mitochondrial malonyl coenzyme A decarboxylase deficiency: a rare inborn error of metabolism. J Inherit Metab Dis 22(Supplement 1): 93 (abstract).
O'Brien DP, Barshop BA, Faunt KK, Johnson GC, Gibson KM, Shelton GD (1999) Malonic aciduria in Maltese dogs: normal methylmalonic acid concentrations and malonyl-CoA decarboxylase activity in fibroblasts. J Inherit Metab Dis 22: 883–890.
Podell M, Shelton GC, Nyhan WL, et al (1996) Methylmalonic and malonic aciduria in a dog with progressive encephalomyelopathy. Metab Brain Dis 11: 239–247.
Santer R, Fingerhut R, Lassker U, et al (2003) Tandem mass spectrometric determination of malonylcarnitine: diagnosis and neonatal screening of malonyl-CoA decarboxylase deficiency. Clin Chem 49: 660–662.
Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30(12): e57.
Surendran S, Sacksteder KA, Gould SJ, et al (2001) Malonyl CoA decarboxylase deficiency: C to T transition in intron 2 of the MCD gene. J Neurosci Res 65: 591–594.
Wightman PJ, Santer R, Ribes A, et al (2003) MLYCD mutation analysis: evidence for protein mistargeting as a cause of MLYCD deficiency. Hum Mutat 22: 288–300.
Zammit VA (1999) The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. Biochem J 343: 505–515.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Johannes Zschocke
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Salomons, G.S., Jakobs, C., Pope, L.L. et al. Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency. J Inherit Metab Dis 30, 23–28 (2007). https://doi.org/10.1007/s10545-006-0514-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0514-6